Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2055040-78-1
859230-20-9
2112731-51-6
2112731-96-9
2055042-31-2
2093153-08-1
1330765-96-2 | 7,10-Dibenzyl-2,7,10-triazaspiro[4.6]undecane | AA019EKH | MFCD20230626
37901-94-3 | 4-Amino-3-methyl-5-nitrobenzoic acid | AA019EN4 | MFCD27950153
322765-94-6 | 2,2,2-trichloroethyl 2-bromo-2-(3,4-dimethoxyphenyl)acetate | AA019EQS | MFCD30145641
936801-42-2 | Ethyl 5-((tert-butoxycarbonyl)amino)-6-methylnicotinate | AA019ETQ | MFCD18256584
52559-36-1 | 1H-Benz[de]isoquinoline-1,3(2H)-dione, 6-bromo- | AA019EX7 | MFCD00453280
4600-04-8 | 1-Phenyl-1H-1,2,3-triazole-4-carboxylic acid | AA019F0T | MFCD02110530
84250-74-8 | 4-Iodo-N-methylaniline hydrochloride | AA019FWD | MFCD12912932
326023-22-7 | 4-Chloro-3-(2-chloro-phenylsulfamoyl)-benzoic acid | AA019GGH | MFCD02704602
750617-49-3 | 3-[(2,3-dimethoxyphenyl)methylidene]-1H,2H,3H-cyclopenta[b]quinoline-9-carboxylic acid | AA019GP6 | MFCD26143497
326034-12-2 | 5-amino-N-(4-methoxyphenyl)-2-(piperidin-1-yl)benzene-1-sulfonamide | AA019GYU | MFCD02225646